Comparative Effectiveness Of Different Recommended Doses Of Omeprazole And Lansoprazole For Gastroesophageal Reflux Disease: A Meta-Analysis Of Published Data
Feng Liu,Jing Wang,Hailong Wu,Hui Wang,Jianxiang Wang,Rui Zhou,Zhi Zhu
2017-01-01
Abstract:This meta-analysis aims to evaluate the effectiveness of different recommended doses of omeprazole and lansoprazole on gastroesophageal reflux diseases (GERD) in adults. The electronic databases of PubMed, EMBASE, Cochrane Library, and ClinicalTrials. gov were searched before September 13 2016. Fifteen eligible studies were identified involving 8752 patients in our meta-analysis. For the healing outcome of esophagitis, compared with 15 mg per day of lansoprazole, there were significant difference of both 30 mg per day of lansoprazole (RR=1.29, 95% CI [1.01, 1.66], I-2=79.3%, P=0.028) and 60 mg per day of lansoprazole (RR=1.59, 95% CI [1.28, 1.99], I-2=Not applicable (NA), P=NA), and the other result were not significantly different between 60 mg per day and 30 mg per day. For relief of symptoms, our result indicated a significant difference between 20 mg per day and 10 mg per day of omeprazole (RR=1.21, 95% CI [1.06, 1.39], I-2=53.9%, P=0.089); the overall result indicated a significant difference between lansoprazole and omeprazole (RR=0.93, 95% CI [0.86, 0.999], I-2=60.7%, P=0.038). This suggests that lansoprazole had superior quality effectiveness and that dose was a critical factor for effectiveness. No publication bias was observed. On the basis of these results, we recommend the use of lansoprazole with higher doses for the treatment of GERD in adults.